Characteristics | IgG Anti-dsDNA(+) n=43 |
IgG+IgM Anti-dsDNA(+) n=15 |
p Valuea |
---|---|---|---|
Female gender (%) | 40 (93) | 13 (86.7) | 0.596 |
Age (years±SD) | 40.6±13.3 | 43.1±12.0 | 0.518 |
Age at diagnosis (years±SD) | 29.7±12.4 | 32.1±10.2 | 0.554 |
Disease duration (years±SD) | 10.5±87.6 | 11.3±9.1 | 0.913 |
Malar rash (%) | 28 (65.1) | 9 (60) | 0.966 |
Discoid rash (%) | 1 (2.3) | 1 (6.7) | 0.454 |
Photosensitivity (%) | 32 (74.4) | 13 (86.7) | 0.480 |
Nasal/oral ulcers (%) | 17 (39.5) | 7 (46.7) | 0.858 |
Arthritis (%) | 31 (72.1) | 12 (80) | 0.736 |
Serositis (%) | 14 (32.6) | 5 (33.3) | 0.999 |
Neurologic manifestations (%) | 9 (20.9) | 1 (6.7) | 0.427 |
Hematologic manifestations (%) | 29 (67.4) | 10 (66.7 ) | 0.999 |
ANA (%) | 43 (100) | 15 (100) | - |
Anti-Sm (%) | 12 (28.6) | 3 (20) | 0.693 |
Anticardiolipin antibodies (%) | 18 (41.9) | 6 (40) | 0.999 |
Lupus anticoagulant (%) | 7 (17.1) | 3 (20) | 0.999 |
False-positive VDRL (%) | 5 (11.6) | 1 (6.7) | 0.999 |
SLEDAIb | 4 (2-6) | 2 (1-8) | 0.361 |
Active nephritisc (%) | 15 (34.9) | 1 (6.7) | 0.046 |
C3 (mg/dL±SD)d | 99.6±29.3 | 96.2±29.6 | 0.706 |
C4 (mg/dL±SD)d | 16±8.9 | 16.67±8.7 | 0.894 |
Sjogren’s syndrome (%) | 4 (9.5) | 0 (0) | 0.564 |
Antiphospholipid syndrome (%) | 4 (9.5) | 0 (0) | 0.564 |